Elicio Therapeutics, Inc. (ELTX) stock
ELTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$1.59+0.16 (+11.19%)
Close on Nov 18, 2026Market cap $41.79MP/E –Yield –
Elicio Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Elicio Therapeutics's price to sales ratio was 4.6× on Jul 31, 2023, against 0.1× a year earlier. Over the last 3 years it ranged from 0.1× to 20.2×, with a median of 3.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Jul 31, 2023 | 4.6× | +4.5 |
| 2022 | Dec 30, 2022 | 0.1× | −3.1 |
| 2021 | Dec 31, 2021 | 3.2× | – |
See a number that looks wrong?